DGAP-News: Xenikos announces IND clearance by the FDA for a pivotal Phase 3 trial using T-Guard(R) for treating steroid-refractory acute GVHD

Press/Media

Period11 Jun 2019

Media coverage

1

Media coverage

  • TitleDGAP-News: Xenikos announces IND clearance by the FDA for a pivotal Phase 3 trial using T-Guard(R) for treating steroid-refractory acute GVHD
    Media name/outletEQS Newsfeed (English)
    Country/TerritoryGermany
    Date11/06/19
    PersonsJohn Levine